JW (Cayman) Therapeutics Co. Ltd JWCTF
JWCTF
JW (Cayman) Therapeutics Co. Ltd MLLCF
Molecular Partners AG SPHDF
Santhera Pharmaceuticals Holding AG BRIBF
Brii Biosciences Limited GNFTF
Genfit S.A. IPHYF
Innate Pharma S.A. NGENF
NervGen Pharma Corp. NDTP
NDT Pharmaceuticals Inc. BXPHF
Botanix Pharmaceuticals Limited SCNLF
Scancell Holdings plc
JW (Cayman) Therapeutics Co. Ltd MLLCF
Molecular Partners AG SPHDF
Santhera Pharmaceuticals Holding AG BRIBF
Brii Biosciences Limited GNFTF
Genfit S.A. IPHYF
Innate Pharma S.A. NGENF
NervGen Pharma Corp. NDTP
NDT Pharmaceuticals Inc. BXPHF
Botanix Pharmaceuticals Limited SCNLF
Scancell Holdings plc
Performance
| Periode | JWCTF | MLLCF | SPHDF | BRIBF | GNFTF | IPHYF | NGENF | NDTP | BXPHF | SCNLF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 44.00 % | -17.06 % | -9.49 % | -7.46 % | 16.95 % | 10.51 % | 95.57 % | 1 266.91 % | -72.81 % | 21.01 % |
| YTD | 122.22 % | -14.84 % | 41.72 % | 91.79 % | 16.95 % | -25.69 % | 128.45 % | 3 484.91 % | -75.36 % | -20.00 % |
| 1Y | 123.05 % | -14.84 % | 41.72 % | 91.79 % | 20.35 % | -25.69 % | 143.12 % | 3 484.91 % | -75.36 % | -20.00 % |
| 3Y | -29.36 % | -41.28 % | -99.05 % | -74.67 % | 24.32 % | -31.15 % | 324.00 % | 1 800.00 % | 215.40 % | -10.00 % |
| 5Y | -87.37 % | -85.42 % | 41 076 823.08 % | -91.25 % | -12.84 % | -49.88 % | 217.37 % | -47.22 % | -28.32 % | 79.33 % |
| 10Y | -87.37 % | -84.53 % | 1 530 963 302 652.29 % | -91.25 % | -88.00 % | -84.85 % | 307.47 % | 1 800.00 % | -60.58 % | -40.74 % |
| From the beginning | -87.37 % | -84.53 % | 29 666 666 566.67 % | -91.25 % | -85.60 % | -86.12 % | 307.47 % | -99.63 % | -60.58 % | -68.00 % |